Galvez, K. (2019). Efficacy of Generic Bortezomib Used as a Part of CyBorD Regimen to Achieve Complete Response in Multiple Myeloma. Innovative Journal of Medical and Health Sciences, 9(1), 247–251. https://doi.org/10.15520/ijmhs.v9i1.2431